Medicare Enrolled
Dr. George Predeteanu, M.D.
Cardiovascular Disease · Flint, MI
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Predeteanu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Predeteanu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Predeteanu
Dr. George Predeteanu is a cardiovascular disease specialist in Flint, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Predeteanu performed 4,292 Medicare services across 2,733 unique beneficiaries.
Between the years covered by Open Payments, Dr. Predeteanu received a total of $14,023 from 57 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Predeteanu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in MI
$14,023 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,292
Medicare services
Top 7% in MI for cardiovascular disease
2,733
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~215 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
761 | $9 | $43 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
743 | $83 | $137 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
516 | $43 | $65 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
366 | $130 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
310 | $62 | $125 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
198 | $140 | $390 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
186 | $47 | $170 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
182 | $326 | $850 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
127 | $15 | $75 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
125 | $102 | $200 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
121 | $18 | $51 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
121 | $53 | $150 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
99 | $22 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $110 | $213 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
58 | $1 | $1 |
| Heart muscle strain imaging | 53 | $28 | $80 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
52 | $54 | $135 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
27 | $18 | $46 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
24 | $620 | $1,400 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $94 | $150 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
19 | $362 | $960 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
15 | $37 | $137 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
15 | $16 | $125 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
15 | $144 | $485 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
14 | $83 | $189 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $124 | $190 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
12 | $19 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $70 | $90 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $137 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
33.0% medium
55.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,023
Total received (2018-2024)
Avg $2,003/year across 7 years
Top 19% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,335 (95.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$644 (4.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,627
2023
$2,639
2022
$1,915
2021
$2,202
2020
$1,182
2019
$2,150
2018
$1,308
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$387
Medtronic, Inc.
$218
AstraZeneca Pharmaceuticals LP
$204
Lexicon Pharmaceuticals, Inc.
$181
Amgen Inc.
$165
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$157
PFIZER INC.
$138
Merck Sharp & Dohme LLC
$136
Alnylam Pharmaceuticals Inc.
$123
E.R. Squibb & Sons, L.L.C.
$119
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
Kiniksa Pharmaceuticals International, plc
$108
Bayer Healthcare Pharmaceuticals Inc.
$99
Janssen Pharmaceuticals, Inc
$87
SCPHARMACEUTICALS INC.
$77
Actelion Pharmaceuticals US, Inc.
$74
Inari Medical, Inc.
$70
Novo Nordisk Inc
$60
Kestra Medical Technology Services, Inc.
$55
Inspire Medical Systems, Inc.
$40
SANOFI-AVENTIS U.S. LLC
$20
Top 3 companies account for 30.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,437
Medtronic, Inc.
$1,250
Amgen Inc.
$952
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$829
PFIZER INC.
$669
Boehringer Ingelheim Pharmaceuticals, Inc.
$665
Medicure Pharma Inc.
$644
Medtronic Vascular, Inc.
$630
Janssen Pharmaceuticals, Inc
$568
AstraZeneca Pharmaceuticals LP
$500
Actelion Pharmaceuticals US, Inc.
$492
Merck Sharp & Dohme LLC
$439
Abbott Laboratories
$409
SANOFI-AVENTIS U.S. LLC
$381
E.R. Squibb & Sons, L.L.C.
$373
Alnylam Pharmaceuticals Inc.
$324
Bayer HealthCare Pharmaceuticals Inc.
$282
Regeneron Healthcare Solutions, Inc.
$227
Boston Scientific Corporation
$220
Amarin Pharma Inc.
$210
Astellas Pharma US Inc
$209
Lexicon Pharmaceuticals, Inc.
$196
Bayer Healthcare Pharmaceuticals Inc.
$170
Gilead Sciences, Inc.
$131
Merck Sharp & Dohme Corporation
$121
Kiniksa Pharmaceuticals, Ltd.
$116
Novo Nordisk Inc
$116
ABIOMED
$114
Lundbeck LLC
$112
Kiniksa Pharmaceuticals International, plc
$108
ARBOR PHARMACEUTICALS, INC.
$101
Esperion Therapeutics, Inc.
$83
SCPHARMACEUTICALS INC.
$77
Daiichi Sankyo Inc.
$77
BOSTON SCIENTIFIC CORPORATION
$73
Inari Medical, Inc.
$70
Kestra Medical Technology Services, Inc.
$67
GENZYME CORPORATION
$61
Aziyo Biologics, Inc.
$58
AcelRx Pharmaceuticals, Inc.
$49
Edwards Lifesciences Corporation
$48
iRhythm Technologies, Inc.
$46
Arbor Pharmaceuticals, Inc.
$45
BIOTRONIK INC.
$44
Inspire Medical Systems, Inc.
$40
Chiesi USA, Inc.
$23
Cardiovascular Systems Inc.
$23
Siemens Medical Solutions USA, Inc.
$19
Getinge USA Sales, LLC
$17
Amryt Pharma Holdings Ltd
$16
Ethicon US, LLC
$16
Relypsa, Inc.
$15
ARALEZ PHARMACEUTICALS US INC.
$13
LifeWatch Services Inc
$13
Otsuka America Pharmaceutical, Inc.
$13
HeartFlow, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
Adempas · Advisa · Amplia MRI · Arcalyst · Assure WCD · BRILINTA · Bidil · BioMonitor · BodyGuardian · CAMZYOS · CARDIOSAVE HYBRID · CHANTIX · CLEVIPREX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DSUVIA · ECM · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FABRAZYME · FABRY-DISEASE · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HemoSphere · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · Juxtapid · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pouch · ReDS · Repatha · Rybelsus · S · SAMSCA · SEEQ · SPECT Symbia Intevo · SURGICEL Family of Absorbable Hemostats · TYPE B PLUG · TYRX · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · Visia AF · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
34
Per 100K population
8.4
County median income
$60,673
Nearest hospital
HURLEY MEDICAL CENTER
2.2 mi
2.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Predeteanu is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 7% in MI), with low-engagement industry engagement in the top 19% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Predeteanu experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Predeteanu performed 761 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Predeteanu receive payments from pharmaceutical companies?
Yes. Dr. Predeteanu received a total of $14,023 from 57 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Predeteanu's costs compare to other cardiologists in Flint?
Dr. Predeteanu's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Predeteanu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Flint
Browse cardiologists in Flint ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology